🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥#WCLC24 Wrap Up‼️ ✅OA10 DLL3 Targeting BiTE Therapies in SCLC 🎙️Jacob sands 🎯Tarlatamab in Prev Treated SCLC: DeLLphi-301 Phase 2 Extended F/U 🎯OS at 6 and 12 months of 73.4% and 56.7% #LCSM IASLC OncoAlert cattendee.abstractsonline.com/meeting/20598

This one was a lot of fun!

It's time for the "Experts vs AI" ADC Challenge—#LungCancer Edition! Join Drs. Sands (Jacob sands), Chiang (@AnneChiangMD) & Rotow (Julia Rotow MD) as they put AI to the test and provide guidance on bringing ADCs to clinical practice. bit.ly/4eoc7Aj #TTLC25 #ExpertsvsAI

Join Dr. Lauren Averett Byers, MD as she leads a session on small cell lung cancer at #TexasLung25, alongside leading experts, this weekend at our 2-day #CE-accredited conference. Register now: hubs.la/Q03g5Pjg0 Noura Choudhury, MD Ticiana Batista (Leal) Pamela Samson, MD Jacob sands Misty Dawn Shields

Such a wonderful time in Hong Kong meeting with brilliant colleagues and discussing advances in small cell lung cancer! Thank you to everybody for the wonderful hospitality. 🙏🏻

Such an amazing organization doing such important work! #LCSM

Join Giannis Mountzios at our next roundtable on #SCLC! He will be joined by Solange Peters and Jacob sands to discuss DLL3-targeted T-cell engagers, evolving therapies, and the latest data on IO combinations. ⏰ 17th June 2025 at 5PM CEST Tune in for free - it's CME-certified ⬇️

Explore the latest progress in treating #SCLC with Jacob sands at our upcoming roundtable, including emerging data on immuno-oncology #IO combination therapies, plus more with Solange Peters and Giannis Mountzios ⏰ 17th June at 5PM CEST Join the discussion for free ⬇️

Explore the important emergence of DLL3-targeted T-cell engagers in #SCLC with Giannis Mountzios at our upcoming roundtable! He'll be joined by Solange Peters and Jacob sands to discuss much more on small cell lung cancer #SCLC. ⏰ 17th June 2025 at 5PM CEST Tune in for free ⬇️

🆕 #ASCO25 🆙 ☑️#LCSM Poster 🔥Results of a phase 1 study of LB2102, a dnTGFβRII armored DLL3-targeted autologous CAR-T cell therapy, in pts with relapsed or refractory SCLC and LCNEC 🎙️ Jacob sands 📌Poster Bd225, Abstr 8104 OncoAlert ASCO LARVOL meetings.asco.org/2025-asco-annu…

LB2102 CAR T-Cell Therapy Is Well Tolerated, Yields Disease Control in R/R SCLC and LCNEC Jacob sands Dana-Farber ASCO #ASCO25 #lcsm #oncology onclive.com/view/lb2102-ca…

Share your anonymous patient case or questions and receive expert guidance from renowned experts at our upcoming session on small cell lung cancer #SCLC with Solange Peters, Giannis Mountzios, and Jacob sands 👩‍⚕️👨‍⚕️ Submit your case or questions below ⬇️

Thank you to our chairs, Drs. Stephen V Liu, MD & Tina Cascone, who made the 3rd annual Texas Lung Cancer Conference an incredible CE-accredited event to remember! SAVE THE DATE for next year: April 9-11, 2026 in Austin, TX. thetlcconference.com/?utm_source=x&… Here are some highlights from

Dr. Jeff Yang MD FACS Mass General Surgery & @HarvardMed shares key updates on surgery for small cell lung cancer & the impact of screening. From new guidelines to national outreach via ALCSI, he's helping shape the future of SCLC care. Watch & subscribe -> youtu.be/YLWvjYrRqHg

There’s a lot to discuss about small cell lung cancer. Looking forward to this discussion soon with exceptional colleagues. The field is moving forward! #LCSM

🚨 TODAY Don't miss today's roundtable on the latest progress in treating small cell lung cancer with renowned experts, Solange Peters, Giannis Mountzios and Jacob sands! #ASCO25 #LCSM ⏰ 17ᵗʰ June at 5PM CEST Tune in for free ⬇️